[Critical review of clinical experimentation with clofibrate in coronary disease].
作者信息
Azzena D, Astengo F
出版信息
Minerva Cardioangiol. 1973 Jul-Aug;21(7):497-502.
PMID:4756344
Abstract
摘要
相似文献
1
[Critical review of clinical experimentation with clofibrate in coronary disease].[氯贝丁酯治疗冠心病临床试验的批判性综述]
Minerva Cardioangiol. 1973 Jul-Aug;21(7):497-502.
2
[Diagnosis and treatment of risk factors in chronic ischemic heart disease].
Z Gesamte Inn Med. 1974 Oct 1;29(19):809-14.
3
[The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].[氯贝丁酯与双嘧达莫联合用于动脉硬化性血管疾病及其并发症的预防和治疗]
G Clin Med. 1977 Nov-Dec;58(11-12):475-86.
4
[Classification of hyperlipoproteinemias in hospitalized patients].[住院患者高脂蛋白血症的分类]
G Clin Med. 1972 Mar;53(3):121-31.
5
[Classification of hyperlipoproteinaemia in primary gout].
Dtsch Med Wochenschr. 1972 Apr 14;97(15):600-4. doi: 10.1055/s-0028-1107404.
6
[Hyperlipiemia and its therapy by clofibrate].[高脂血症及其氯贝丁酯治疗]
Iryo. 1969 Dec;23(12):1473-8.
7
8
The influence of drugs affecting lipids on atherosclerosis.
Horm Metab Res. 1974;Suppl 4:191-4.
9
[Therapy and prevention of arteriosclerosis].[动脉硬化的治疗与预防]
Z Alternsforsch. 1971;24(4):301-20.
10
[Clinical picture of the type-3-hyperlipoproteinemia].
Verh Dtsch Ges Inn Med. 1971;77:596-9.
Zotero 插件